Your browser doesn't support javascript.
loading
Response to Pham et al., "More data are needed to confirm the utility of screening for atypical fibroxanthoma and pleomorphic dermal sarcoma recurrence".
Ørholt, Mathias; Eriksson, Frank; Herly, Mikkel; Vester-Glowinski, Peter.
Affiliation
  • Ørholt M; Department of Plastic Surgery and Burns Treatment, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark. Electronic address: Mathias.oerholt.nielsen@regionh.dk.
  • Eriksson F; Section of Biostatistics, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
  • Herly M; Department of Plastic Surgery and Burns Treatment, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Vester-Glowinski P; Department of Plastic Surgery and Burns Treatment, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
J Am Acad Dermatol ; 90(5): e175-e176, 2024 May.
Article in En | MEDLINE | ID: mdl-38185254

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Histiocytoma, Malignant Fibrous Type of study: Diagnostic_studies / Screening_studies Limits: Humans Language: En Journal: J Am Acad Dermatol Year: 2024 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Histiocytoma, Malignant Fibrous Type of study: Diagnostic_studies / Screening_studies Limits: Humans Language: En Journal: J Am Acad Dermatol Year: 2024 Document type: Article Country of publication: United States